Advertisement
Canada markets open in 4 hours 8 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7326
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    83.74
    +0.17 (+0.20%)
     
  • Bitcoin CAD

    87,970.85
    +516.24 (+0.59%)
     
  • CMC Crypto 200

    1,389.65
    -6.88 (-0.49%)
     
  • GOLD FUTURES

    2,364.00
    +21.50 (+0.92%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,717.00
    +149.50 (+0.85%)
     
  • VOLATILITY

    15.59
    +0.22 (+1.43%)
     
  • FTSE

    8,109.23
    +30.37 (+0.38%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Shareholders Are Thrilled That The OrganiGram Holdings (TSE:OGI) Share Price Increased 245%

The last three months have been tough on OrganiGram Holdings Inc. (TSE:OGI) shareholders, who have seen the share price decline a rather worrying 38%. But in stark contrast, the returns over the last half decade have impressed. It's fair to say most would be happy with 245% the gain in that time. We think it's more important to dwell on the long term returns than the short term returns. The more important question is whether the stock is too cheap or too expensive today.

Check out our latest analysis for OrganiGram Holdings

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

ADVERTISEMENT

During the five years of share price growth, OrganiGram Holdings moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. Indeed, the OrganiGram Holdings share price has gained 20% in three years. Meanwhile, EPS is up 256% per year. This EPS growth is higher than the 6.3% average annual increase in the share price over the same three years. Therefore, it seems the market has moderated its expectations for growth, somewhat.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

TSX:OGI Past and Future Earnings, November 22nd 2019
TSX:OGI Past and Future Earnings, November 22nd 2019

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. Dive deeper into the earnings by checking this interactive graph of OrganiGram Holdings's earnings, revenue and cash flow.

A Different Perspective

While the broader market gained around 12% in the last year, OrganiGram Holdings shareholders lost 30%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 28%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.